Cointime

Intact Genomics

company

About

Intact Genomics provides high-quality life science products and large DNA fragment cloning related services

  • 1 - 10

Highlights

Total Funding Amount
$1.50M
Funding Rounds
2
Investors
1

Details

Last Funding Type
Grant
Industries
Biopharma,Biotechnology,Clinical Trials,Health Care,Medical Device
Founded date
Jan 1, 2013
Number Of Employee
1 - 10
Operating Status
Active

Intact Genomics is a world leader in large DNA fragment cloning and metagenomic technologies. We have dedicated scientists and state of the art equipment all housed in a modern facility, located in the Helix Center Biotech Incubator, next to Monsanto Headquarters, Donald Danforth Plant Science Center, and close to Washington University in St. Louis

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.50M
Intact Genomics has raised a total of $1.50M in funding over 2 rounds. Their latest funding was raised on Jun 1, 2018 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 1, 2018 Grant $1.50M 1 National Institutes of Health — Detail
Jul 12, 2016 Grant — 1 National Institutes of Health — Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Intact Genomics is funded by 1 investors. National Institutes of Health are the most recent investors.
Investor Name Lead Investor Funding Round
National Institutes of Health Yes Grant
Cointime
เนื้อหา
บริษัท